All In Biotech

Drug Trial Radar · NCT04218084

Study to Evaluate the Effect of GBT440 on TCD in Pediatrics With Sickle Cell Disease

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Voxelotor (GBT440) in Pediatric Participants With Sickle Cell Disease (HOPE Kids 2)

Last checked: Nov 20, 2026Latest source record: Mar 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 236 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

236

Actual

Start

Nov 11, 2020

Primary completion

Jan 18, 2024

Study completion Nov 6, 2024

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
Jan 6, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 2 years, up to 14 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Phase 3, randomized, double-blind, placebo-controlled study of voxelotor in pediatric participants, aged ≥ 2 to \< 15 years old, with Sickle Cell Disease. The primary objective is to evaluate the effect of voxelotor on the TCD (Transcranial Doppler Ultrasound) measurements in SCD participants in this age range.

Conditions

  • Sickle Cell Disease

Interventions

  • VoxelotorDrug

    Participants are randomized 1:1 to receive voxelotor or placebo.

  • PlaceboDrug

    Matching placebo.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Time-Averaged Maximum of Mean Velocity (TAMMV) Arterial Cerebral Blood Flow at Week 24Time frame: Baseline (value at screening), Week 24

Locations

35 sites in 9 countries. Site status is shown where the registry gives one.

  • Children's National Medical Center

    Washington D.C., District of Columbia

  • University of Miami

    Miami, Florida

  • Children's Healthcare of Atlanta: Hughes Spalding

    Atlanta, Georgia

  • Boston Children's Hospital - Clinical Research Pharmacy

    Boston, Massachusetts

  • Boston Children's Hospital

    Boston, Massachusetts

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Medical University of South Carolina: Investigational Drug Services

    Charleston, South Carolina

  • Medical University of South Carolina: Shawn Jenkins Women's and Children's Hospital

    Charleston, South Carolina

  • Medical University of South Carolina

    Charleston, South Carolina

  • Texas Children's Hospital - Investigational Pharmacy

    Houston, Texas

  • Texas Children's Hospital- Wallace Tower

    Houston, Texas

  • Texas Children's Hospital

    Houston, Texas

  • Alexandria Clinical Research Center, Faculty of Medicine, Alexandria University

    Alexandria, Egypt

  • Abu El Rich Hospital, Cairo University Hospital

    Cairo, Egypt

  • Ain Shams University Hospital- Clinical Research Center (MASRI)

    Cairo, Abassia, Egypt

  • Zagazig University Hospital

    Zagazig, Alsharkia, Egypt

  • Komfo Anokye Teaching Hospital

    Kumasi, Ashanti Region, Ghana

  • Department of Child Health, University of Ghana Medical School, College of Health Sciences, Korle-Bu

    Accra, Greater Accra Region, Ghana

  • Azienda Ospedaliera Universitaria Meyer "A.O.U. Meyer" - SOC "Oncologia, Ematologia e TCSE"

    Florence, Italy

  • Azienda Ospedaliera Universitaria (A.O.U.) "Luigi Vanvitelli"

    Naples, Italy

  • Azienda Ospedaliera Universita' (AOU ) Padova

    Padova, Italy

  • Azienda Ospedaliera Universita' (AOU) Padova

    Padova, Italy

  • KEMRI CRDR Clinical Research Annex

    Nairobi, Kenya

  • Strathmore University Medical Centre

    Nairobi, Kenya

  • Gertrude's Children Hospital

    Nairobi, Kenya

  • Kemri/Crdr,Siaya,Kemri Clinical Research Annex

    Kisumu, Siaya County, Kenya

  • University of Nigeria Teaching Hospital

    Enugu, Nigeria

  • Barau Dikko Teaching/Kaduna State University

    Kaduna, Nigeria

  • Aminu Kano Teaching Hospital

    Kano, Nigeria

  • Lagos University Teaching Hospital

    Surulere, Lagos, Nigeria

  • College of Medicine, University of Ibadan

    Ibadan, Oyo State, Nigeria

  • Sultan َQaboos University Hospital

    Muscat, Oman

  • King Abdullah International Medical Research Center (KAIMRC), Ministry of National Guard - Health

    Riyadh, Saudi Arabia

  • Barts Health NHS Trust

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.